Report from the IBS AB Annual General Meeting on April 22, 2008

Report from the IBS AB Annual General Meeting on April 22, 2008

Stockholm, Sweden April 22, 2008. The Annual General Meeting of IBS shareholders
held on April 22 discharged the Members of the Board and the President from
personal liability for the 2007 fiscal year. 

IBS Board
Members of the Board Dr. Pallab Chatterjee, Fredrik Svensson, Gunnel Duveblad,
Bertrand Sciard and Vinit Bodas were re-elected. The Meeting also resolved to
newly elect Bo Pettersson and George Ho as Members of the Board. Dr. Pallab
Chatterjee was re-elected Chairman of the Board. 

Audit Company
KPMG Bohlins AB, with Åsa Wirén Linder as auditor-in-charge, was re-elected IBS'
audit company for the period extending until the close of the 2012 Annual
General Meeting.

Board and Auditor fees
The Meeting adopted the Nomination Committee's motion concerning the following
director fees: SEK 600,000 for the Chairman of the Board, Dr. Pallab Chatterjee,
SEK 200,000 each for Vinit Bodas, Bo Pettersson, George Ho and Fredrik Svensson
and SEK 250,000 each for Gunnel Duveblad and Bertrand Sciard. Dr. Pallab
Chatterjee is to be paid an additional SEK 150,000 as travel-time compensation,
since he is based in Dallas, Texas, USA. Finally, supplementary fees amounting
to at most SEK 300,000 will be distributed to the Members of the Board appointed
to committees according to the Board's decisions. Accordingly, total director
fees will amount to not more than SEK 2,350,000. 

It was resolved, as before, that auditor' fees are paid in return for separate
invoices.

Incentive program and transfer of own shares 
The meeting adopted the Board's proposal for a call option program for the
Company's President and other members of the management group and certain key
employees (in total about 20 persons). The call option program shall comprise a
maximum of 2,240,000 options, each of which will carry entitlement to receive a
cash amount corresponding to the listed share price of the company's B share,
less the exercise price at the time of exercise of the option. The board shall
execute the program prior to the expiry of the present fiscal year.

As a consequence of the incentive program, the Company may, in conjunction with
the exercise of the options, with waiver of the preferential rights of
shareholders, transfer a maximum of 2,240,000 B shares in the Company at a sales
price which is equivalent to the above mentioned exercise price. A proposal
regarding transfer of own shares will be presented at the 2011 AGM. The number
of shares and the sales price of shares comprised by this decision may need to
be re-calculated as a result of e.g. bonus issues, shares splits, reversed share
splits, issues of new shares and similar measures.

Other resolutions
Other resolutions passed by the Meeting related to the Board of Directors'
motion regarding guidelines for remuneration of senior executives and a motion
concerning procedures for the appointment of a new Nomination Committee. 

Complete minutes covering all of the resolutions made by the Meeting will be
available at www.ibs.net under the Investors tab. 


For further information, please contact: 

Camilla Moore, Information Director, IBS AB 
Tel: +46-70-555 12 39
camilla.moore@ibs.net 


IBS (OMX Nordic Exchange STO: IBS) is a leading provider of specialized business
systems for specific industries such as publishing and book distribution,
pharmaceutical distribution, electronics, paper, food and the automotive
industry. IBS focuses on large and mid-sized companies within supply chain
management, demand-driven manufacturing, customer administration and financial
control. For further information, visit www.ibs.net